A Rapid Systematic Review of Factors Influencing COVID-19 Vaccination Uptake in Minority Ethnic Groups in the UK.
COVID-19
barrier
facilitator
minority ethnicity
vaccine uptake
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
01 Oct 2021
01 Oct 2021
Historique:
received:
03
09
2021
revised:
16
09
2021
accepted:
21
09
2021
entrez:
26
10
2021
pubmed:
27
10
2021
medline:
27
10
2021
Statut:
epublish
Résumé
COVID-19 has disproportionately affected minority ethnic groups in the United Kingdom. To maximise the effectiveness of the vaccination programme, it is important to understand and address disparities in vaccine uptake. The aim of this review was to identify factors influencing COVID-19 vaccination uptake between minority ethnic groups in the UK. A search was undertaken in peer-reviewed databases, polling websites and grey literature from January 2020-May 2021. Studies were included if they reported data on vaccine uptake or the reasons for or against accepting the COVID-19 vaccination for minority ethnic groups in the UK. Twenty-one papers met the inclusion criteria, all of which were rated as either good or moderate quality. Ethnic minority status was associated with higher vaccine hesitancy and lower vaccine uptake compared with White British groups. Barriers included pre-existing mistrust of formal services, lack of information about the vaccine's safety, misinformation, inaccessible communications, and logistical issues. Facilitators included inclusive communications which address vaccine concerns via trusted communicators and increased visibility of minority ethnic groups in the media. Community engagement to address the concerns and informational needs of minority ethnic groups using trusted and collaborative community and healthcare networks is likely to increase vaccine equity and uptake.
Identifiants
pubmed: 34696228
pii: vaccines9101121
doi: 10.3390/vaccines9101121
pmc: PMC8541490
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : UK Research and Innovation
ID : ES/W001721/1
Références
Vaccine. 2021 Apr 28;39(18):2595-2603
pubmed: 33810905
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Vaccine. 2021 Jul 5;39(30):4046-4053
pubmed: 34140173
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Vaccines (Basel). 2021 Oct 01;9(10):
pubmed: 34696228
Psychol Med. 2022 Oct;52(14):3127-3141
pubmed: 33305716
Br J Gen Pract. 2021 Dec 31;72(714):e51-e62
pubmed: 34750106
Br J Gen Pract. 2021 Jul 29;71(709):e583-e595
pubmed: 33875420
Health Expect. 2021 Aug;24(4):1158-1167
pubmed: 33942948
Brain Behav Immun. 2021 May;94:41-50
pubmed: 33713824
EClinicalMedicine. 2020 Dec;29:100630
pubmed: 33200120
Lancet Reg Health Eur. 2021 Oct;9:100180
pubmed: 34308406
Vaccines (Basel). 2021 Jan 04;9(1):
pubmed: 33406762
Psychol Med. 2023 Jan;53(1):236-247
pubmed: 33843509
J R Soc Med. 2021 May;114(5):240-243
pubmed: 33689530
Vaccine. 2020 Nov 17;38(49):7789-7798
pubmed: 33109389